Session 2-B: Mastering the Biotech Funding Game: Trends and Strategies
Click on their image to learn more about each speaker
Sophia Su, MBBS, MS
Investment Director, Junson Capital
Joshua Reynolds, PhD
Founder and CEO, Atlas Biotech
Thomas Kim, JD
President and CEO, EpiVario, Inc. & ReEngage Therapeutics; Corporate attorney; IP attorney